• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Factors influencing 20-hour increments after platelet transfusion.

作者信息

Bishop J F, Matthews J P, McGrath K, Yuen K, Wolf M M, Szer J

机构信息

Department of Haematology and Medical Oncology, Peter MacCallum Cancer Institute, Melbourne, Victoria, Australia.

出版信息

Transfusion. 1991 Jun;31(5):392-6. doi: 10.1046/j.1537-2995.1991.31591263191.x.

DOI:10.1046/j.1537-2995.1991.31591263191.x
PMID:2048176
Abstract

The 20-hour posttransfusion platelet count determines transfusion policy for patients requiring platelet support, and yet factors influencing the 20-hour count have been poorly defined. The clinical factors influencing both the 1- and 20-hour corrected count increment (CCI), were studied in 623 human leukocyte antigen (HLA)-unmatched platelet transfusions in 108 patients. The 1- and 20-hour CCIs were highly correlated (r = 0.67, p less than 0.001). On average, the 20-hour CCI was 64 percent of the 1-hour CCI. Multiple linear regression analyses identified splenectomy, bone marrow transplantation, disseminated intravascular coagulation, administration of amphotericin B, palpable spleen, and HLA antibody grade as the major factors influencing the 20-hour posttransfusion CCI. Platelet-specific antibodies, number of concurrent antibiotics, clinical bleeding, and temperature did not significantly influence the 20-hour posttransfusion CCI. The 1-hour CCI was the only significant factor influencing the 20-hour CCI in a regression model containing the 1-hour CCI and the above factors. Thus, the same clinical factors exert a major influence on the CCI at both 1 and 20 hours after platelet transfusion, with no evidence that any factor has more influence at 20 hours after transfusion than at 1 hour.

摘要

相似文献

1
Factors influencing 20-hour increments after platelet transfusion.
Transfusion. 1991 Jun;31(5):392-6. doi: 10.1046/j.1537-2995.1991.31591263191.x.
2
Clinical factors influencing the efficacy of pooled platelet transfusions.影响混合血小板输注疗效的临床因素。
Blood. 1988 Feb;71(2):383-7.
3
Determination viability of a transfused platelet product by corrected count increment and percentage platelet response.通过校正计数增加值和血小板反应百分比来确定输注血小板产品的活力。
Pan Afr Med J. 2017 Jul 28;27:226. doi: 10.11604/pamj.2017.27.226.12116. eCollection 2017.
4
[Thrombocyte transfusion: increase in platelets in relation to clinical and immunologic prerequisites].[血小板输注:与临床和免疫学前提条件相关的血小板增加情况]
Infusionsther Klin Ernahr. 1987 Apr;14 Suppl 2:10-4.
5
Clinical factors influencing posttransfusion platelet increment in patients undergoing hematopoietic progenitor cell transplantation--a prospective analysis.影响造血干细胞移植患者输血后血小板增量的临床因素——一项前瞻性分析。
Transfusion. 1998 Sep;38(9):839-47. doi: 10.1046/j.1537-2995.1998.38998409004.x.
6
[Improvement of bleeding tendency and normalized platelet count increment following splenectomy in a patient with refractory anemia].[难治性贫血患者脾切除术后出血倾向改善及血小板计数增量恢复正常]
Rinsho Ketsueki. 1997 Jun;38(6):532-8.
7
Platelet transfusion therapy. One-hour posttransfusion increments are valuable in predicting the need for HLA-matched preparations.
JAMA. 1980 Feb 1;243(5):435-8. doi: 10.1001/jama.243.5.435.
8
Cumulative donor-specific antibody threshold predicts platelet transfusion response in HLA-alloimmunized patients.累积供者特异性抗体阈值可预测 HLA 同种免疫患者的血小板输注反应。
Blood Adv. 2024 Sep 10;8(17):4689-4699. doi: 10.1182/bloodadvances.2024014143.
9
Human leukocyte antigen (HLA)-incompatible mean fluorescence intensity-selected platelet products have corrected count increments similar to HLA antigen-matched platelets.人类白细胞抗原 (HLA)-不相容的平均荧光强度选择血小板产品的校正计数增加与 HLA 抗原匹配的血小板相似。
Transfusion. 2021 Aug;61(8):2307-2316. doi: 10.1111/trf.16430. Epub 2021 Jun 1.
10
Incubation of platelet concentrates before transfusion does not improve posttransfusion recovery.
Transfusion. 1990 Oct;30(8):701-3. doi: 10.1046/j.1537-2995.1990.30891020327.x.

引用本文的文献

1
Response to apheretic platelet transfusion in children of acute lymphoblastic leukemia receiving induction chemotherapy: a cross-sectional study from Bangladesh.急性淋巴细胞白血病诱导化疗患儿对单采血小板输注的反应:一项来自孟加拉国的横断面研究
Ann Med Surg (Lond). 2024 Feb 2;86(3):1346-1351. doi: 10.1097/MS9.0000000000001780. eCollection 2024 Mar.
2
Factors Influencing Corrected Count Increment After Platelet Transfusion in Thrombocytopenic Patients.影响血小板减少症患者血小板输注后校正计数增加值的因素
Cureus. 2023 Sep 28;15(9):e46161. doi: 10.7759/cureus.46161. eCollection 2023 Sep.
3
Dynamics of Platelet Counts in Major Trauma: The Impact of Haemostatic Resuscitation and Effects of Platelet Transfusion-A Sub-Study of the Randomized Controlled RETIC Trial.
严重创伤中血小板计数的动态变化:止血复苏的影响及血小板输注的效果——随机对照RETIC试验的一项子研究
J Clin Med. 2020 Jul 28;9(8):2420. doi: 10.3390/jcm9082420.
4
The assessment of platelet function by thromboelastometry as a point-of-care test to guide Intercept-treated platelet support in hemato-oncological patients and hematopoietic stem cell transplantation recipients.血栓弹力描记法评估血小板功能作为一种即时检测手段,以指导接受 Intercept 治疗的血小板支持在血液肿瘤患者和造血干细胞移植受者中的应用。
Transfusion. 2020 Jul;60(7):1391-1399. doi: 10.1111/trf.15783. Epub 2020 Apr 22.
5
Platelet Transfusion: And Update on Challenges and Outcomes.血小板输注:挑战与结果的最新进展
J Blood Med. 2020 Jan 24;11:19-26. doi: 10.2147/JBM.S234374. eCollection 2020.
6
Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period.围手术期患者输血管理的建议。II. 手术期。
Blood Transfus. 2011 Apr;9(2):189-217. doi: 10.2450/2011.0075-10.
7
Recommendations for the transfusion of plasma and platelets.血浆和血小板输注的建议。
Blood Transfus. 2009 Apr;7(2):132-50. doi: 10.2450/2009.0005-09.
8
Modification of solid phase red cell adherence assay for the detection of platelet antibodies in patients with thrombocytopenia.改良固相红细胞黏附试验用于检测血小板减少症患者的血小板抗体
Am J Clin Pathol. 2008 Sep;130(3):455-66. doi: 10.1309/1QWTQFMF0Q9JEAGR.
9
Failing to live up to the fanfare? A personal perspective on obstacles to the clinical development of thrombopoietic agents.辜负了大肆宣传?关于血小板生成剂临床开发障碍的个人观点。
Int J Hematol. 2001 Dec;74(4):390-6. doi: 10.1007/BF02982081.